Literature DB >> 11223438

Coronary artery disease in patients at low risk--apolipoprotein AI as an independent risk factor.

M C Francis1, J J Frohlich.   

Abstract

Many risk factors for coronary artery disease (CAD) have been established by large epidemiological studies. However, some patients without the major risk factors still develop disease. Preliminary analysis of individuals referred for angiography, who had no major risk factors associated with CAD, indicated that apolipoprotein-AI (apoAI) was significantly lower in patients with positive angiograms. The hypothesis that apoAI was an independent risk factor for CAD in low risk populations was put forth. One thousand and seventy-five consecutive patients underwent angiography, lipid analysis, and completed a risk factor questionnaire. Individuals with total cholesterol<5.2 mmol/l, high density lipoprotein (HDL)-cholesterol>0.9 mmol/l, systolic blood pressure<140 mmHg and diastolic blood pressure<90 mmHg, no diabetes, and no family history of premature CAD in first degree relatives were selected. Fifty-four patients met these selection criteria, 29 having positive evidence of CAD and 25 with no evidence of disease. Multivariate analysis revealed that, after adjusting for age and gender, serum apoAI level was the only variable predictive of CAD. This effect was independent of HDL cholesterol level and fractional esterification rate of HDL (FER(HDL)). These results point to an important role for apoAI in the atherogenic process, particularly in populations with no major CAD risk factors. Decreased levels of apoAI or LpAI may initiate atherosclerosis in a highly selected group of low risk patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223438     DOI: 10.1016/s0021-9150(00)00528-1

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  10 in total

1.  Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort.

Authors:  Kenny W J Lee; John S Hill; Keith R Walley; Jiri J Frohlich
Journal:  CMAJ       Date:  2006-02-14       Impact factor: 8.262

2.  Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease.

Authors:  Taranjit Singh Rai; Madhu Khullar; B S Sehrawat; Monica Ahuja; Praveen Kumar Sharma; Rajesh Vijayvergiya; Anil Grover
Journal:  Mol Cell Biochem       Date:  2008-04-09       Impact factor: 3.396

3.  Gene-Gene Interactions among Pparα/δ/γ Polymorphisms for Apolipoprotein (Apo) A-I/Apob Ratio in Chinese Han Population.

Authors:  Bo Hai; Huijian Xie; Zhirong Guo; Chen Dong; Ming Wu; Qiu Chen; Zhengyuan Zhou; Qiurong Zhu; Mengmeng Liu; Wei Fan; Hui Zhou
Journal:  Iran J Public Health       Date:  2014-06       Impact factor: 1.429

4.  Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.

Authors:  Richard L Dunbar; Rajesh Movva; LeAnne T Bloedon; Danielle Duffy; Robert B Norris; Mohamad Navab; Alan M Fogelman; Daniel J Rader
Journal:  Clin Transl Sci       Date:  2017-08-09       Impact factor: 4.689

5.  Association of the HNF1A polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke.

Authors:  Yi-Jiang Zhou; Rui-Xing Yin; Shao-Cai Hong; Qian Yang; Xiao-Li Cao; Wu-Xian Chen
Journal:  J Gene Med       Date:  2017-01       Impact factor: 4.565

6.  Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study.

Authors:  Liang Gao; Yaju Zhang; Xingmin Wang; Hongli Dong
Journal:  BMC Endocr Disord       Date:  2021-04-01       Impact factor: 2.763

7.  Hsp70-2 gene polymorphism: susceptibility implication in Tunisian patients with coronary artery disease.

Authors:  Mohamed Yahia Hrira; Latifa Chkioua; Afef Slimani; Henda Chahed; Habib Mosbah; Hamda Ben Khaldoun; Salima Ferchichi; Faouzi Addad; Abdelhedi Miled
Journal:  Diagn Pathol       Date:  2012-07-26       Impact factor: 2.644

8.  Neighbourhood socioeconomics status predicts non-cardiovascular mortality in cardiac patients with access to universal health care.

Authors:  Claire L Heslop; Gregory E Miller; John S Hill
Journal:  PLoS One       Date:  2009-01-07       Impact factor: 3.240

Review 9.  Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.

Authors:  Sven-Olof Olofsson; Olov Wiklund; Jan Borén
Journal:  Vasc Health Risk Manag       Date:  2007

10.  Influence of vanadium on serum lipid and lipoprotein profiles: a population-based study among vanadium exposed workers.

Authors:  Yang Zhang; Qin Zhang; Chengyong Feng; Xiaohui Ren; Hong Li; Keping He; Faxuan Wang; Dinglun Zhou; Yajia Lan
Journal:  Lipids Health Dis       Date:  2014-02-24       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.